
You are here
Consultations
We conduct public consultations as part of our broader stakeholder engagement work, including on changes to regulatory requirements or practices, reviews of business processes, standards or guidelines, and TGA fees and charges.
Filters
Status
Categories
- Advertising (2) Apply Advertising filter
- Australian Register of Therapeutic Goods (ARTG) (1) Apply Australian Register of Therapeutic Goods (ARTG) filter
- Biologicals (2) Apply Biologicals filter
- Complementary medicines (7) Apply Complementary medicines filter
- Remove Cosmetics filter Cosmetics (0)
- Fees/Payments (1) Apply Fees/Payments filter
- Import/Export (1) Apply Import/Export filter
- Labelling/Packaging (1) Apply Labelling/Packaging filter
- Legislation (3) Apply Legislation filter
- Remove Listed medicines filter Listed medicines (2)
- Manufacturing (1) Apply Manufacturing filter
- Medical devices/IVDs (55) Apply Medical devices/IVDs filter
- Medical devices safety (1) Apply Medical devices safety filter
- Medicinal cannabis (1) Apply Medicinal cannabis filter
- Medicines (2) Apply Medicines filter
- Medicines safety (1) Apply Medicines safety filter
- Remove OTC medicines filter OTC medicines (12)
- Remove Other therapeutic goods filter Other therapeutic goods (1)
- Prescription medicines (6) Apply Prescription medicines filter
- Remove Safety of medicines & medical devices filter Safety of medicines & medical devices (0)
- Remove Scheduling filter Scheduling (55)
- Therapeutic Goods Administration (TGA) (2) Apply Therapeutic Goods Administration (TGA) filter
- Therapeutic goods regulation (2) Apply Therapeutic goods regulation filter
- (-) Remove Listed medicines filter Listed medicines
- (-) Remove Safety of medicines & medical devices filter Safety of medicines & medical devices
- (-) Remove OTC medicines filter OTC medicines
- (-) Remove Cosmetics filter Cosmetics
- (-) Remove Other therapeutic goods filter Other therapeutic goods
- (-) Remove Scheduling filter Scheduling
Notice of interim decisions on proposed amendments to the Poisons Standard – Joint ACMS-ACCS #25 - June 2020
Closed on 11 April 2022
Notice of interim decisions on proposed amendments to the Poisons Standard – ACMS #36 ACCS #32 Joint ACMS-ACCS #29 - November 2021
Closed on 11 April 2022
Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, March 2022
Closed on 31 January 2022
Notice of interim decisions on proposed amendments to the Poisons Standard – ACCS #31 – June 2021
Closed on 11 November 2021
Notice of interim decisions on proposed amendments to the Poisons Standard - Joint ACMS-ACCS #28 - June 2021
Closed on 11 November 2021
Notice of interim decisions on proposed amendments to the Poisons Standard (sodium nitrite) - June 2021
Closed on 11 November 2021
Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS #34 - June 2021
Closed on 1 November 2021
Notice of interim decisions on proposed amendments to the Poisons Standard - ACMS #34 (oral contraceptive substances) - June 2021
Closed on 1 November 2021
Proposed amendments to the Poisons Standard - ACCS, ACMS and joint ACCS/ACMS meetings, November 2021
Closed on 7 October 2021
Proposed changes to Required Advisory Statements for Medicine Labels (RASML): Melatonin
Closed on 17 September 2021